Search results

Old Dominion Freight Line ODFL is scheduled to report second-quarter 2026 results on July 29, before the market opens.

The Zacks Consensus Estimate for second-quarter 2026 earnings has been revised

Astera Labs ALAB is benefiting from robust demand for its Taurus portfolio, which is driving significant growth and positioning the company for further upside. The Taurus product line, focused on

Bank OZK OZK reported second-quarter 2026 earnings per share (EPS) of $1.49, which surpassed the Zacks Consensus Estimate of $1.46. However, the bottom line declined 5.7% year over year from $1.58.

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Old Dominion Freight Line (ODFL), which

Fomento Economico Mexicano, S.A.B. de C.V. FMX, or FEMSA, is slated to report second-quarter 2026 earnings on July 28. The company is likely to have witnessed top and bottom-line growth in the

IBM (IBM) came out with quarterly earnings of $2.93 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $2.8 per share a year ago. These figures are adjusted for

Essential Properties (EPRT) came out with quarterly funds from operations (FFO) of $0.5 per share, in line with the Zacks Consensus Estimate . This compares to FFO of $0.46 per share a year ago

Huntington Bancshares (HBAN) came out with quarterly earnings of $0.39 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.38 per share a year ago. These figures

MarineMax (HZO) came out with quarterly earnings of $0.81 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.49 per share a year ago. These figures are adjusted

Ladder Capital (LADR) came out with quarterly earnings of $0.24 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.23 per share a year ago. These figures are

Interparfums, Inc. IPAR announced its sales results for the second quarter, which ended June 30, 2026. The results reflected modest top-line growth, driven by strong U.S. performance and favorable

Medtech giant Johnson & Johnson JNJ reported better-than-expected second-quarter 2026 results, surpassing Wall Street estimates on both the top and bottom lines. The quarterly performance was

RTX Corporation’s RTX second-quarter 2026 adjusted earnings per share (EPS) of $1.89 beat the Zacks Consensus Estimate of $1.66 by 13.9%. The bottom line improved 21.1% from the year-ago quarter’s

Raymond James’ RJF third-quarter fiscal 2026 (ended June 30) adjusted earnings of $3.14 per share beat the Zacks Consensus Estimate of $2.91. The bottom line increased 44% from the prior-year

Texas Instruments TXN reported second-quarter 2026 earnings of $2.14 per share, which increased 52% year over year. The bottom line beat the Zacks Consensus Estimate by 12%.

TXN’s earnings surpassed

Ameriprise Financial’s AMP second-quarter 2026 adjusted operating earnings were $11.07 per share, which handily surpassed the Zacks Consensus Estimate of $10.72. The bottom line reflected a rise of

SEI Investments Co.’s SEIC  second-quarter 2026 adjusted earnings per share of $1.66 surpassed the Zacks Consensus Estimate of $1.45. The bottom line reflected a rise of 38.3% from the prior-year

Packaging Corporation of America PKG reported second-quarter 2026 adjusted earnings of $2.35 per share, down 5.2% year over year but beating the Zacks Consensus Estimate of $2.31. The bottom line

Eli Lilly LLY is a dominant player in the cardiometabolic market, backed by a strong and expanding GLP-1 portfolio. Its GLP-1 lineup includes Mounjaro and Zepbound (tirzepatide injections) for type